Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05098054

A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function

Conditions: Hepatic Impairment, Healthy Volunteers

Sex: All

Ages: 18 Years – 75 Years

Healthy volunteers: Yes

Phase: PHASE1

Enrollment: 36

Sponsor: Takeda

Location: Velocity Edgewater Florida

Summary

The main aim is to check the effect of a single dose of soticlestat in adults with moderate or mild liver failure compared to healthy adults with normal liver function. Participants will check into the study clinic for 8 days. During the stay, one oral dose of soticlestat will be given and the participant will be monitored. The clinic staff will follow up with the participant about a week after discharge from the clinic.

Eligibility Criteria

Inclusion Criteria A. For Participants with Hepatic Impairment 1. Has a BMI greater than or equal to (\>=) 18.0 and less than or equal to (\=18.0 and \=80/40 millimeter of mercury (mmHg) (asymptomatic) and \=40 beats per minute (bpm) and \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05098054). StuddyBuddy aggregates publicly available trial information.